COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project

Autor: Megan Rutter, Peter C Lanyon, Matthew J Grainge, Richard Hubbard, Mary Bythell, Peter Stilwell, Jeanette Aston, Sean McPhail, Sarah Stevens, Fiona A Pearce

Publikováno v: Rheumatology.

Objectives To calculate the rates of COVID-19 infection and COVID-19-related death among people with rare autoimmune rheumatic diseases (RAIRD) during the second wave of the COVID-19 pandemic in England, and describe the impact of corticosteroids on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::666567598d4bb4dd7317f4c1d1159fe2
https://doi.org/10.1093/rheumatology/kead150

The incidence of Kawasaki disease using hospital admissions data for England 2006–2021

Autor: Myron Odingo, Megan Rutter, Jonathan Bowley, Emily J Peach, Peter C Lanyon, Matthew J Grainge, Peter Stillwell, Sean McPhail, Mary Bythell, Jeanette Aston, Sarah Stevens, Rachael McCormack, Paul Brogan, Fiona A Pearce

Publikováno v: Rheumatology.

Objective To describe the incidence of Kawasaki Disease (kDa) between 2006 and 2021 in England. Methods We identified all cases in hospital episode statistics with an ICD-10 diagnostic code M303 (for kDa) between 1 April 2006 and 31 March 2021. We va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5edeb43c0eeb533dcd012ca4e4e0cab5
https://doi.org/10.1093/rheumatology/kead051

Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statistics

Autor: Jennifer R Hannah, Patrick A Gordon, James Galloway, Megan Rutter, Emily J Peach, Michael Rooney, Peter Stilwell, Matthew J Grainge, Peter C Lanyon, Mary Bythell, Fiona A Pearce

Publikováno v: Rheumatology advances in practice. 6(3)

Objective Hospital episode statistics (HES) are routinely recorded at every hospital admission within the National Health Service (NHS) in England. This study validates diagnostic ICD-10 codes within HES as a method of identifying cases of idiopathic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec69a03967fe9fa7d0b4bfa460c0d595
https://pubmed.ncbi.nlm.nih.gov/36532317

Primary care consultations after hospitalisation for pneumonia: a large population-based cohort study

Autor: Rowan H. Harwood, Vadsala Baskaran, Tricia M. McKeever, Wei Shen Lim, Fiona A Pearce

Publikováno v: The British Journal of General Practice

BackgroundUp to 70% of patients report ongoing symptoms 4 weeks after hospitalisation for pneumonia; the impact on primary care is poorly understood.AimTo investigate the frequency of primary care consultations after hospitalisation for pneumonia, an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6274d6e7a828b989a27af3f59027bfcb
http://europepmc.org/articles/PMC8007276

Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE—data from the BSR audit of systemic lupus erythematosus

Autor: Elizabeth MacPhie, Ravinder Sandhu, Megan Rutter, Jayne Little, Hannah Guest, Rebecca L Batten, Caroline Gordon, Fiona A Pearce, Ali Rivett, Nicola Erb, Karen Obrenovic, Jon Packham, Ian N. Bruce, Nehal Narayan, Rozeena Garner, Chris Hiley, Peter Lanyon, Charlotte A Sharp, Bridget Griffiths

Publikováno v: Rutter, M, Lanyon, P, Sandhu, R, Batten, R, Garner, R, Little, J, Narayan, N, Sharp, C, Bruce, I, Erb, N, Griffiths, B, Guest, H, Macphie, E, Packham, J, Hiley, C, Obrenovic, K, Rivett, A, Gordon, C & Pearce, F A 2021, ' Estimation of the burden of shielding among a cross section of patients attending rheumatology clinics with SLE – data from the BSR audit of Systemic Lupus Erythematosus ', Rheumatology
, vol. 60, no. 3, pp. 1474 – 1479 . https://doi.org/10.1093/rheumatology/keaa620
Rheumatology (Oxford, England)

Objectives We aimed to estimate what proportion of people with SLE attending UK rheumatology clinics would be categorized as being at high risk from coronavirus disease 2019 (COVID-19) and therefore asked to shield, and explore what implications this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a60b8154ff0bf363b80f78bd121237de
https://doi.org/10.1093/rheumatology/keaa620